Literature DB >> 19640976

Human Ubc9 contributes to production of fully infectious human immunodeficiency virus type 1 virions.

Tareq Jaber1, Christopher R Bohl, Gentry L Lewis, Charles Wood, John T West, Robert A Weldon.   

Abstract

Ubc9 was identified as a cellular protein that interacts with the Gag protein of Mason-Pfizer monkey virus. We show here that Ubc9 also interacts with the human immunodeficiency virus type 1 (HIV-1) Gag protein and that their interaction is important for virus replication. Gag was found to colocalize with Ubc9 predominantly at perinuclear puncta. While cells in which Ubc9 expression was suppressed with RNA interference produced normal numbers of virions, these particles were 8- to 10-fold less infectious than those produced in the presence of Ubc9. The nature of this defect was assayed for dependence on Ubc9 during viral assembly, trafficking, and Env incorporation. The Gag-mediated assembly of virus particles and protease-mediated processing of Gag and Gag-Pol were unchanged in the absence of Ubc9. However, the stability of the cell-associated Env glycoprotein was decreased and Env incorporation into released virions was altered. Interestingly, overexpression of the Ubc9 trans-dominant-negative mutant C93A, which is a defective E2-SUMO-1 conjugase, suggests that this activity may not be required for interaction with Gag, virion assembly, or infectivity. This finding demonstrates that Ubc9 plays an important role in the production of infectious HIV-1 virions.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19640976      PMCID: PMC2753122          DOI: 10.1128/JVI.00237-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  78 in total

1.  Intracellular trafficking of Gag and Env proteins and their interactions modulate pseudotyping of retroviruses.

Authors:  Virginie Sandrin; Delphine Muriaux; Jean-Luc Darlix; François-Loïc Cosset
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

2.  SUMO-1 modification of IkappaBalpha inhibits NF-kappaB activation.

Authors:  J M Desterro; M S Rodriguez; R T Hay
Journal:  Mol Cell       Date:  1998-08       Impact factor: 17.970

Review 3.  HIV-1 gag proteins: diverse functions in the virus life cycle.

Authors:  E O Freed
Journal:  Virology       Date:  1998-11-10       Impact factor: 3.616

4.  hUBC9 associates with MEKK1 and type I TNF-alpha receptor and stimulates NFkappaB activity.

Authors:  A Saltzman; G Searfoss; C Marcireau; M Stone; R Ressner; R Munro; C Franks; J D'Alonzo; B Tocque; M Jaye; Y Ivashchenko
Journal:  FEBS Lett       Date:  1998-04-03       Impact factor: 4.124

5.  Polarized human immunodeficiency virus budding in lymphocytes involves a tyrosine-based signal and favors cell-to-cell viral transmission.

Authors:  J Deschambeault; J P Lalonde; G Cervantes-Acosta; R Lodge; E A Cohen; G Lemay
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

6.  The ubiquitin-like proteins SMT3 and SUMO-1 are conjugated by the UBC9 E2 enzyme.

Authors:  S E Schwarz; K Matuschewski; D Liakopoulos; M Scheffner; S Jentsch
Journal:  Proc Natl Acad Sci U S A       Date:  1998-01-20       Impact factor: 11.205

7.  Evidence that HIV budding in primary macrophages occurs through the exosome release pathway.

Authors:  Deborah Greene Nguyen; Amy Booth; Stephen J Gould; James E K Hildreth
Journal:  J Biol Chem       Date:  2003-10-14       Impact factor: 5.157

8.  Cell-type-dependent targeting of human immunodeficiency virus type 1 assembly to the plasma membrane and the multivesicular body.

Authors:  Akira Ono; Eric O Freed
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

9.  Novel single-cell-level phenotypic assay for residual drug susceptibility and reduced replication capacity of drug-resistant human immunodeficiency virus type 1.

Authors:  Haili Zhang; Yan Zhou; Cecily Alcock; Tara Kiefer; Daphne Monie; Janet Siliciano; Quan Li; Paul Pham; Joseph Cofrancesco; Deborah Persaud; Robert F Siliciano
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

10.  A conserved tryptophan-rich motif in the membrane-proximal region of the human immunodeficiency virus type 1 gp41 ectodomain is important for Env-mediated fusion and virus infectivity.

Authors:  K Salzwedel; J T West; E Hunter
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

View more
  20 in total

Review 1.  Human pathogens and the host cell SUMOylation system.

Authors:  Peter Wimmer; Sabrina Schreiner; Thomas Dobner
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

Review 2.  Viral manipulation of cellular protein conjugation pathways: The SUMO lesson.

Authors:  Domenico Mattoscio; Chiara V Segré; Susanna Chiocca
Journal:  World J Virol       Date:  2013-05-12

3.  The SUMOylation of matrix protein M1 modulates the assembly and morphogenesis of influenza A virus.

Authors:  Chung-Yi Wu; King-Song Jeng; Michael M-C Lai
Journal:  J Virol       Date:  2011-04-20       Impact factor: 5.103

4.  Allosteric Inhibition of Ubiquitin-like Modifications by a Class of Inhibitor of SUMO-Activating Enzyme.

Authors:  Yi-Jia Li; Li Du; Jianghai Wang; Ramir Vega; Terry D Lee; Yunan Miao; Grace Aldana-Masangkay; Eric R Samuels; Baozong Li; S Xiaohu Ouyang; Sharon A Colayco; Ekaterina V Bobkova; Daniela B Divlianska; Eduard Sergienko; Thomas D Y Chung; Marwan Fakih; Yuan Chen
Journal:  Cell Chem Biol       Date:  2018-12-20       Impact factor: 8.116

5.  Impairment of human immunodeficiency virus type-1 integrase SUMOylation correlates with an early replication defect.

Authors:  Alessia Zamborlini; Audrey Coiffic; Guillaume Beauclair; Olivier Delelis; Joris Paris; Yashuiro Koh; Fabian Magne; Marie-Lou Giron; Joelle Tobaly-Tapiero; Eric Deprez; Stephane Emiliani; Alan Engelman; Hugues de Thé; Ali Saïb
Journal:  J Biol Chem       Date:  2011-03-21       Impact factor: 5.157

6.  SUMO-conjugating enzyme E2 UBC9 mediates viral immediate-early protein SUMOylation in crayfish to facilitate reproduction of white spot syndrome virus.

Authors:  An-Jing Chen; Lu Gao; Xian-Wei Wang; Xiao-Fan Zhao; Jin-Xing Wang
Journal:  J Virol       Date:  2012-10-24       Impact factor: 5.103

7.  Live cell visualization of the interactions between HIV-1 Gag and the cellular RNA-binding protein Staufen1.

Authors:  Miroslav P Milev; Chris M Brown; Andrew J Mouland
Journal:  Retrovirology       Date:  2010-05-10       Impact factor: 4.602

8.  Assessing predictions of fitness effects of missense mutations in SUMO-conjugating enzyme UBE2I.

Authors:  Jing Zhang; Lisa N Kinch; Qian Cong; Jochen Weile; Song Sun; Atina G Cote; Frederick P Roth; Nick V Grishin
Journal:  Hum Mutat       Date:  2017-09       Impact factor: 4.878

9.  Elevated global SUMOylation in Ubc9 transgenic mice protects their brains against focal cerebral ischemic damage.

Authors:  Yang-Ja Lee; Yongshan Mou; Dragan Maric; Dace Klimanis; Sungyoung Auh; John M Hallenbeck
Journal:  PLoS One       Date:  2011-10-07       Impact factor: 3.240

10.  Human Ubc9 is involved in intracellular HIV-1 Env stability after trafficking out of the trans-Golgi network in a Gag dependent manner.

Authors:  Christopher R Bohl; Levon G Abrahamyan; Charles Wood
Journal:  PLoS One       Date:  2013-07-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.